Drugs / JKN2401
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07330310 | Mar 2026 → Sep 2027 expected | chronic obstructive pulmonary disease | Joincare Pharmaceutical Group Industry Co., Ltd | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JKN2401 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07330310 ↗ |
| Route | Subcutaneous | “JKN2401 subcutaneous injection, Q4W” NCT07330310 ↗ |